NYS families to access more fresh produce via $8M USDA grant

Cornell researchers are helping to improve and expand a program that makes fresh, locally grown fruits and vegetable more affordable for New York state families with low incomes.

Absorbable scaffold beats angioplasty for lower-leg artery disease

In patients with severe artery blockage in the lower leg, an artery-supporting device called a resorbable scaffold is superior to angioplasty, according to the results of a large international clinical trial co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.

Banerjee named Mellon Fellow in diversity network

A consortium of 13 research institutions, including Cornell, received a $1.5 million grant from The Andrew W. Mellon Foundation to launch the Ivy+ Mellon Leadership Fellows program this fall.

Fighting for better health care in sub-Saharan Africa

Osei Boateng ’18, MHA ’20, founder of OKB Hope Foundation, a nonprofit dedicated to transforming health care delivery in Africa, is the latest guest on the Startup Cornell podcast.

Around Cornell

Drug screen points toward novel diabetes treatments

A drug currently in clinical trials as a cancer therapy can also stimulate pancreatic beta cells to secrete insulin, revealing a previously unknown mechanism for insulin regulation in Type 2 diabetes, according to a new study by Weill Cornell Medicine investigators.

Service to science: Two veterans find purpose in neuroscience

After service in the military, Chris Brunkhorst and Caleb Jones sought new outlets to channel their discipline and their commitment to helping others – and they both found it in neuroscience.

Around Cornell

Boosting beta cells to treat Type 2 diabetes

Researchers at Weill Cornell Medicine have uncovered a novel route to stimulate the growth of healthy insulin-producing pancreatic beta cells in a preclinical model of diabetes. The findings hold promise for future therapeutics that will improve the lives of individuals with Type 2 diabetes – a condition that affects more than 500 million people worldwide.

Lewis Lab investigates intriguing role of osteocytes in bone health

A special type of cell, called an osteocyte, may hold the key to some of the mysteries of osteoporosis. A research group led by Karl Lewis, assistant professor of biomedical engineering, is studying osteocytes in unique new ways.

Around Cornell

Pesticides detected in beeswax

An analysis of beeswax in managed honeybee hives in New York finds a wide variety of pesticide, herbicide and fungicide residues, exposing current and future generations of bees to long-term toxicity.